sábado, 14 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 16, 2026

Aduro Clean Technologies présente les résultats financiers de son deuxième trimestre 2026 et fait le point sur ses activités

View original at globenewswire.com
“Le chiffre d’affaires du deuxième trimestre 2026 ressort à 122 706 dollars, soit une progression marquée de 222 % par rapport aux 38 143 dollars enregistrés au deuxième trimestre 2025.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Hydrochemolytic™ technology is cost-effective and operates at relatively low temperatures for plastic waste chemical recycling, heavy crude oil/bitumen upgrading, and renewable fuels transformation

    80% confidence
  • Operating loss increased 107% to $(6,461,987) in Q2 FY2026 vs $(3,114,712) in Q2 FY2025, driven by share-based compensation, derivative financial liability revaluation loss, increased R&D, technology scaling, hiring, marketing/PR, and Nasdaq listing costs

    80% confidence
  • Steam cracking test results showed stable furnace operation with ethylene/propylene yields comparable to traditional fossil fuel-based feedstocks, providing favorable data supporting further evaluation of HCT-derived liquids for steam cracking applications

    80% confidence
  • Adjusted EBITDA provides nuanced operational performance view and shows amounts available for working capital and future growth

    80% confidence
  • Revenue increased 222% in Q2 FY2026 to $122,706 CAD compared to $38,143 in Q2 FY2025

    80% confidence
  • Final site selection for Netherlands demonstration plant expected by end of January 2026

    80% confidence
  • Shell GameChanger collaboration validated key process design assumptions under continuous operation and supports Aduro's scaling journey from pilot to demonstration phase

    80% confidence

Data points we hold from this source

Aduro Clean Technologies Inc. · adjusted ebitda-3299026 CAD
Aduro Clean Technologies Inc. · property plant equipment7729984 CAD
Aduro Clean Technologies Inc. · share based compensation1860246 CAD
Aduro Clean Technologies Inc. · other income-131172 CAD
Aduro Clean Technologies Inc. · derivative liability fair value change1284420 CAD
Aduro Clean Technologies Inc. · depreciation amortization149467 CAD
Aduro Clean Technologies Inc. · revenue122706 CAD
Aduro Clean Technologies Inc. · operating loss-3114712 CAD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Aduro Clean Technologies présente les résultats financiers de son deuxième trimestre 2026 et fait le point sur ses activités — Source | Via News | pt.VIA.NEWS